Algeta to Participate in Upcoming Investor Conferences

Marketwired

OSLO, NORWAY--(Marketwired - Aug 12, 2013) - Algeta ASA (OSE: ALGETA), a company focused onthe development of novel targeted cancer therapeutics, announces thatmembers ofits executive management team will participate in the followingupcominginvestor conferences:

Wedbush Life Sciences Management Access Conference

Date: 13-14 August 2013

Participants:

Andrew Kay (President & CEO)

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Presentation date: Tuesday 13 August 2013

Venue: New York City, NY, USA


Morgan Stanley Global Healthcare Conference

Date: 9-11 September 2013

Participants:

Andrew Kay (President & CEO)

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Presentation date: Monday 9 September 2013

Venue: New York City, NY, USA


J.P. Morgan Cazenove London Small/Mid-Cap 1x1 Conference

Date: 11-12 September 2013

Participants:

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Venue: London, UK


Bank of America Merrill Lynch Global Healthcare Conference

Date: 11-13 September 2013

Participants:

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Presentation date: Friday 13 September 2013

Venue: London, UK

Presentations, where applicable, will be available to download atwww.algeta.comfollowing these events.

About Algeta

Algeta is a company focused on developing novel targeted therapies forpatientswith cancer based on its alpha-pharmaceutical platform. The Company isheadquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,based inCambridge, MA performing commercial marketing operations in the US. Algetaislisted on the Oslo Stock Exchange (ALGETA.OL). For more informationpleasevisit www.algeta.com.

Press release:

http://hugin.info/134655/R/1721685/573429.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE

[HUG#1721685]

Contact:

For further information, please contact:
Mike Booth / Renate Birkeli
Communications & Corporate Affairs
+47 23 00 67 32
Email Contact

Media enquiries:

Mark Swallow
Citigate Dewe Rogerson
+44 207 638 9571
Email Contact

Knut Ekern
Gambit Hill & Knowlton
+47 22 04 82 00
Email Contact

Kari Watson
MacDougall Biomedical Communications
+1 781 235 3060
Email Contact

US investor enquiries:
Tricia Swanson
The Trout Group
+1 646 378 2953
Email Contact

View Comments (0)